Merck & Co. has won approval from the European Commission of its Capvaxive pneumococcal disease vaccine for adults. The Rahway, N.J., drugmaker on Wednesday said the approval covers the 21-valent ...

Merck opened a 225,000-square-foot facility dedicated solely to expanding vaccine manufacturing. The Rahway-based research-intensive biopharmaceutical announced the launch of the $1 billion ...

Merck (NYSE:MRK) stock in focus as the company partners with Jiangsu Hengrui in a $2B deal for heart disease therapy HRS-5346 ...

Merck & Co. has agreed to license an investigational oral small molecule lipoprotein (a) inhibitor from Jiangsu Hengrui Pharmaceuticals in a deal potentially worth more than $2 billion to the Chinese ...

RAHWAY, N.J. - Merck & Co., Inc. (NYSE ... pending the drug’s approval. With a strong P/E ratio of 13.6 and consistent dividend payments for 55 consecutive years, InvestingPro data reveals ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

RAHWAY, N.J., February 24, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Caroline Litchfield, executive vice president and ...

Merck & Co., Inc. is a health care company ... The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co. has won approval from the European Commission of its Capvaxive pneumococcal disease vaccine for adults. The Rahway, N.J., drugmaker on Wednesday said the approval covers the 21-valent ...

We recently published a list of Should You Buy the Dip and Follow Insiders into These 10 Stocks?. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against ...

RAHWAY, N.J., March 12, 2025--Merck Announces Data from Phase 3 Trials that Show Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir Maintained HIV-1 Viral Suppression ...